Biosociality and susceptibility genes: A cautionary tale

Biosocialities, Genetics and the Social Sciences: Making Biologies and Identities

Volumn , Issue , 2007, Pages 56-78

  Lock, Margaret ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL SOCIETY OF CANADA   (Canada)

^c L'Ordre National du Québec   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958727062     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203945940     Document Type: Chapter

References (71)

1. Abraham, C. (2005) "Would You Gaze Into a Genetic Crystal Ball?" The Globe and Mail, Quebec edn: A 1, 9-10.
2. Agence Nationale d'Accrédition et d'Évaluation en Santé (ANAES) (2000)"Recommandations Pratiques Pour le Diagnostic de la Maladie d'Alzheimer. Texte Des Recommandations." Recommandations pour la Pratique Clinique. ANAES. Online. Available HTTP: http://www.anaes.fr/ (accessed June 2006).
3. Alzheimer Society of Canada (2002) Alzheimer Disease and Heredity. Online.Toronto, Alzheimer Canada. Available HTTP: http://www.alzheimer.ca/english/disease/causesheredity.htm (accessed June 2006).
4. Alzheimer's Association UK (2002) "Fact Sheet" (Pamphlet).
5. Alzheimer's Society (2003) Dementia Care and Research: Policy Positions. Online. Available HTTP: www.alzheimers.org.uk (accessed June 2006).
6. Alzheimer's Society (2005) Facts about Dementia. Online. Available HTTP: http://www.alzheimers.org.uk/Facts_about_dementia/index.htm (accessed June 2006).
7. American College of Medical Genetics/American Society of Human Genetics Working Group on APOE and Alzheimer Disease (1995) "Statement on Use of Apolipoprotein E Testing for Alzheimer Disease," Jama, 274: 1627-9.
8. Ballenger, J. F. (2006) Self, Senility, and Alzheimer's Disease in Modern America: A History, Baltimore, MD: Johns Hopkins University Press.
9. Beach, T. G. (1987) "The History of Alzheimer's Disease: Three Debates," Journal of the History of Medicine and Allied Sciences, 42: 327-49.
10. Bertram, L. and Tanzi, R. E. (2004) "Alzheimer's Disease: One Disorder, Too Many Genes?" Human Molecular Genetics 13 Spec No. 1: R135-41.
11. Breitner, J. C. (1999) "The End of Alzheimer's Disease?" International Journal of Geriatric Psychiatry, 14: 577-86.
12. Corbo, R.M. and Scacchi, R. (1999) "Apolipoprotein E (APOE) Allele Distribution in the World. Is APOEε4 a 'Thrifty' Allele?" Annals of Human Genetics, 63 (Pt 4): 301-10.
13. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. (1993) "Gene Dose of Apolipoprotein E type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families," Science, 261: 921-3.
14. Creighton, S., Almqvist, E. W., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., Welch, J. P., Riddell, C., Lokkesmoe, R., Khalifa, M., Mackenzie, J., Sajoo, A., Farrell, S., Robert, F., Shugar, A., Summers, A., Meschino, W., Allingham- Hawkins, D., Chiu, T., Hunter, A., Allanson, J., Hare, H., Schween, J., Collins, L., Sanders, S., Greenberg, C., Cardwell, S., Lemire, E., Macleod, P. and Hayden, M. R. (2003) "Predictive, Pre-natal and Diagnostic Genetic Testing for Huntington's Disease: the Experience in Canada from 1987 to 2000," Clinical Genetics, 63: 462-75.
15. Cupples, L. A., Farrer, L. A., Sadovinick, A. D., Relkin, N., Whitehouse, P. and Green, R. C. (2004) "Estimating Risk Curves for First-Degree Relatives of Patients with Alzheimer's Disease: the REVEAL Study," Genetic Medicine, 6: 192-6.
16. Duster, T. (1990) Backdoor to Eugenics, New York and London: Routledge.
17. Eaton, M. L. (1999) "Surrogate Decision Making for Genetic Testing for Alzheimer Disease," Genetic Testing, 3: 93-7.
18. Farlow, M. R., He, Y., Tekin, S., Xu, J., Lane, R., Charles H. C., (2004) "Impact of APOE in Mild Cognitive Impairment," Neurology, 63: 1898-901.
19. Farrer, L. A. (2000) "Familial Risk for Alzheimer Disease in Ethnic Minorities: Nondiscriminating Genes," Archives of Neurology, 57: 28-9.
20. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., Myers, R. H., Pericak-Vance, M. A., Risch, N. and Van Duijn, C. M. (1997) "Effects of Age, Sex, and Ethnicity on the Association between Apolipoprotein E Genotype and Alzheimer Disease. A Meta-Analysis." APOE and Alzheimer Disease Meta Analysis Consortium. Jama, 278: 1349-56.
21. Fox, P. (1989) "From Senility to Alzheimer's Disease: the Rise of the Alzheimer's Disease Movement," Milbank Q, 67: 58-102.
22. Franzen, J. (2001) "My Father's Brain: What Alzheimer's takes away," The New Yorker, 10 September: 85.
23. Green, R. C., Clarke, V. C., Thompson, N. J., Woodard, J. L. and Letz, R. (1997) "Early Detection of Alzheimer Disease: Methods, Markers, and Misgivings." Alzheimer's Disease and Associated Disorders, 11, Suppl. 5: S1-5; discussion S37-9.
24. Growdon, J. H. (1998) "Apolipoprotein E and Alzheimer's Disease," Archives of Neurology, 55: 1053-4.
25. Gubrium, J. F. (2000) "Narrative Practice and the Inner Worlds of the Alzheimer Disease Experience," In Whitehouse, P. J., Maurer, K. and Ballenger, J. F. (eds) Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives, Baltimore, MD: Johns Hopkins University Press.
26. Hacking, I. (1986) "Making up People," In Heller, T. C., Sosna, M. and Wellerby, D. E. (eds) Reconstructing Individualism: Autonomy, Individuality, and Self in Western Thought, Stanford, CA: Stanford University Press.
27. Halpern, S. (2005) "The Gene Hunters: Closing in on the Origins of Alzheimer's Disease," The New Yorker: 84-93.
28. Hardy, J. (1997) "The Alzheimer Family of Diseases: Many Etiologies, One Pathogenesis?" Proc Natl Acad Sci USA, 94: 2095-7.
29. Health Canada (2001) "Genetic Testing for Late Onset Diseases: In-Depth Thematic Analysis of Policy and Jurisdictional Issues." Ministry of Supply and Services.
30. Holstein, M. (1997) "Alzheimer's Disease and Senile Dementia, 1885-1920: An Interpretive History of Disease Negotiation," Journal of Aging Studies, 11: 1-13.
31. Hyman, B. T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F. and Wallace, R. (1996) "Apolipoprotein E and Cognitive Change in an Elderly Population," Annals of Neurology, 40: 55-66.
32. Ince, P. G. (2001) "Random, Chance, or Hazard?" J Clin Pathol, 54: 254.
33. Jablonka, E. and Lamb, M. J. (2005) Evolution in Four Dimensions: Genetic, Epigenetic, Behavioral, and Symbolic Variation in the History of Life, Cambridge, MA: MIT Press.
34. Journal of the American Medical Association (2001) American College of Medical Genetics Position Statement: Genetic Testing for Late-Onset Alzheimer's Disease. Online. AGS Ethics Committee. Available from: http://www.americangeriatrics.org/products/positionpapers/gen_test.shtml (accessed May 2004).
35. Katzman, R. (1976) "Editorial: The Prevalence and Malignancy of Alzheimer Disease. A Major Killer," Archives of Neurology, 33: 217-8.
36. Kerr, A., Cunningham-Burley, S. and Amos, A. (1998) "The New Genetics and Health: Mobilizing Lay Expertise," Public Understanding of Science, 7: 41-60.
37. Khachaturian, Z. S. (1997) "Plundered Memories," The Sciences, 37: 21-5.
38. Kier, F. J. and Molinari, V. (2003) " 'Do-it-yourself' Dementia Testing: Issues Regarding an Alzheimer's Home Screening Test," Gerontologist, 43: 295-301.
39. Korovaitseva, G. I., Shcherbatykh, T. V., Selezneva, N. V., Gavrilova, S. I., Golimbet, V. E., Voskresenskaia, N. I. and Rogachev, E. I. (2001) "Genetic Association Between the Apolipoprotein E [ApoE] Gene Alleles and Various Forms of Alzheimer's Disease," Human Genetics, 37: 422-2.
40. LaRusse, S., Roberts, J. S., Marteau, T. M., Katzen, H., Linnenbringer, E. L., Barber, M., Whitehouse, P., Quaid, K., Brown, T., Green, R. C. and Relkin, N. R. (2005) "Genetic Susceptibility Testing Versus Family History-Based Risk Assessment: Impact on Perceived Risk of Alzheimer Disease," Genetic Medicine, 7: 48-53.
41. Latour, B. (1993) We Have Never Been Modern, Cambridge, MA: Harvard University Press.
42. Lock, M. (2005) "Eclipse of the Gene and the Return of Divination," Current Anthroplogy, 46: S47-S70.
43. Lock M., Lloyd S. and Prest J., (2006) "Genetic Susceptibility and Alzheimer's Disease: The Penetrance and Uptake of Genetic Knowledge," in Leibing, A. and Cohen, L. (eds) Thinking about Dementia: Culture, Loss and the Anthropology of Senility, Piscataway, NJ: Rutgers University Press.
44. Lock, M., Freeman, J., Sharples, R. and Lloyd, S. (2006) "When it Runs in the Family: Putting Susceptibility Genes in Perspective," Public Understanding of Science, 15: 277-300.
45. Lock, M., Freeman, J., Padowsky, M. Chilibeck, G. and Beveridge, B. (in press) "Susceptibility Genes and the Question of Embodied Identity."
46. McConnell, L. M., Koenig, B. A., Greely, H. T. and Raffint, A. (1998) "Genetic Testing and Alzheimer Disease: Has the Time Come?" Nature Medicine, 4: 757-9.
47. Moss, L. (2003) What Genes Can't Do, Cambridge, MA: MIT Press.
48. Myers, R. H., Schaeffer, E. J., Wilson, P. W., D'Agostino, R., Ordovas, J. M., Espino, A., Au, R., White, R. F., Knoefel, J. E., Cobb, J. L., McNulty, K. A., Beiser, A. and Wolf, P. A. (1996) "Apolipoprotein E Epsilon4 Association with Dementia in a Populationbased Study: The Framingham Study," Neurology, 46: 673-7.
49. Nelkin, D. and Tancredi, L. R. (1989) Dangerous Diagnostics: the Social Power of Biological Information, New York: Basic Books.
50. Novas, C. and Rose, N. (2000) "Genetic Risk and the Birth of the Somatic Individual," Economy and Society, 29: 485-513.
51. Novek S. (2006) "The Struggle for Symbolic Understanding: A Qualitative Analysis of Caregivers' Experiences with Dementia," unpublished thesis, McGill University.
52. Offit, K., Groeger, E., Turner, S., Wadsworth, E. A. and Weiser, M. A. (2004) "The 'Duty to Warn' A Patient's Family Members about Hereditary Disease Risks," Jama, 292: 1469-73.
53. Oyama, S., Griffiths, P. E. and Gray, R. D. (2001) Cycles of Contingency: Developmental Systems and Evolution, Cambridge, MA: MIT Press.
54. Rabinow, P. (1994) "The Third Culture," History of the Human Sciences, 7: 53-64.
55. Relkin, N. R., Kwon, Y. J., TSAI, J. and Gandy's, S. (1996) "The National Institute on Aging/Alzheimer's Association Recommendations on the Application of Apolipoprotein E genotyping to Alzheimer's Disease," Ann N Y Acad Sci, 802: 149-76.
56. Richards, M. (1996) "Lay and Professional Knowledge of Genetics and Inheritance," Public Understanding of Science, 5: 217-30.
57. Risner, M. E., Saunders, A. M., Altman, J. F., Ormandy, G. C., Craft, S., Foley, I. M., Zwartau-Hind, M. E., Hosford, D. A. and Roses, A. D. (2006) "Efficacy of Rosiglitazone in a Genetically Defined Population with Mild-to-Moderate Alzheimer's Disease," Pharmacogenomics Journal, 6(2): 246-54.
58. Roberts, J. S., Cupples, A., Relkin, N. R., Whitehouse, P. and Green, R. (2005) "Genetic Risk Assessment for Adult Children of People with Alzheimer's Disease: the Risk Evaluation and Education for Alzheimer Disease (REVEAL) Study," Journal of Geriatric Psychiatry and Neurology, 18: 250-5.
59. Rose, S. P. R. (2005) The Future of the Brain: the Promise and Perils of Tomorrow's Neuroscience, Oxford and New York: Oxford University Press.
60. Roses, A. D. (1998) "Apolipoprotein E and Alzheimer's Disease: The Tip of the Susceptibility Iceberg." Annals of the New York Academy of Sciences, 855: 738-43.
61. Saunders, A. M. (2000) "Apolipoprotein E and Alzheimer Disease: an Update on Genetic and Functional Analyses." Journal Neuropathology and Experimental Neurology, 59: 751-8.
62. Selkoe, D. J. (2002) "The Pathophysiology of Alzheimer's Disease," in Scinto, L.F.M.and Daffner, K.R. (eds) Early Diagnosis of Alzheimer's Disease, Totowa, NJ: Humana Press.
63. Silverman, J. M., Smith, C. J., Marin, D. B., Mohs, R. C. and Propper, C. B. (2003) "Familial Patterns of Risk in Very Late-Onset Alzheimer Disease," Archives of General Psychiatry, 60: 190-7.
64. Sleegers, K., Roks, G., Theuns, J., Aulchenko, Y. S., Rademakers, R., Cruts, M., van Gool, W. A., van Broeckhoven, C., Heutink, P., Oostra, B. A., van Swieten, J. C. and van Duijn, C.M. (2004) "Familial Clustering and Genetic Risk for Dementia in a Genetically Isolated Dutch Population," Brain, 127: 1641-9.
65. St George-Hyslop, P. H. (2000) "Molecular Genetics of Alzheimer's Disease," Biological Psychiatry, 47: 183-99.
66. Templeton, A. R. (1998) "The Complexity of the Genotype-Phenotype Relationship and the Limitations of Using Genetic 'Markers' at the Individual Level," Science in Context, 11: 373-89.
67. Tilley, L., Morgan, K. and Kalsheker, N. (1998) "Genetic Risk Factors in Alzheimer's Disease," Molecular Pathology, 51: 293-304.
68. Turney, J. (1995) "The Public Understanding of Genetics - Where next?" European Journal of Genetics and Society, 1: 5-22.
69. Weiss, K. and Buchanan, A. V. (2003) "Evolution by Phenotype: a Biomedical Perspective," Perspectives in Biology and Medicine, 46: 159-82.
70. Whitehouse, P. J. (2001) "The End of Alzheimer Disease," Alzheimer's Disease and Associated Disorders, 15: 59-62.
71. Zick, C. D., Mathews, C. J., Roberts, J. S., Cook-Deegan, R., Pokorski, R. J. and Green, R. C. (2005) "Genetic Testing for Alzheimer's Disease and its Impact on Insurance Purchasing Behavior," Health Affairs(Millwood), 24: 483-90.